Competition in context

Addressing the business implications and risks of antitrust issues

Global businesses and their senior executives face significant domestic and international competition issues arising out of merger activity, relationships with third parties, compliance, investigations, regulatory enforcement, criminal proceedings and civil litigation. Our antitrust and competition hub is designed to assist you in navigating the evolving and increasingly complex regulatory, compliance and government enforcement environment.

Latest insights

Climate risk management: An overview of recent key developments for financial institutions

On July 4, 2024, the Autorité des marchés financiers (AMF, Quebec’s financial services regulator) published the final iteration of its “Climate Risk Management Guideline” (the Guideline).

Canada | Publication | 十一月 01, 2024

EU

The European Union (EU) framework for foreign direct investment (FDI) screening is set out in Regulation 2019/452 (as amended, the Current FDI Regulation). In January 2024, the EC adopted a proposal for a new FDI screening regulation (the Proposal) to strengthen and further harmonize FDI screening in the EU.

Global | Publication | 十一月 01, 2024

Mission impossible? Teresa Ribera’s mission letter and the future of EU merger review

Executive Vice President Vestager’s momentous tenure as Commissioner responsible for EU competition policy is nearing its end.

Global | Publication | 十月 28, 2024

Agreement on new EU gas projects and measures under the European Green Deal

On November 28, 2023, the European Commission (EC) adopted its first list of Projects of Common Interest (PCIs), i.e., projects within the EU territory, and Projects of Mutual Interest (PMIs), i.e., projects connecting the EU with other countries, including 166 projects implementing the European Green Deal.

Global | Publication | 十月 24, 2024

Omni-channel without omni-risk: How to manage multiple channels to market under Australian competition law

This article discussed Channel management, Merger control, Changes to unfair contract terms law, and Greenwashing and ESG collaboration.

Australia | Publication | 十月 24, 2024

FTC’s watchdog role in pharma mergers: Road bumps and the way forward

The FTC's revised merger guidelines issued in 2023 signify a substantial alteration in antitrust enforcement, notably impacting industries like pharmaceuticals where consolidation is prevalent.

United States | Publication | 十月 18, 2024